Geode Capital Management’s MediciNova MNOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$745K Buy
543,843
+14,260
+3% +$21.6K ﹤0.01% 3450
2025
Q4
$694K Sell
529,583
-119
-0% -$164 ﹤0.01% 3481
2025
Q3
$668K Buy
529,702
+3,810
+0.7% +$4.93K ﹤0.01% 3518
2025
Q2
$689K Sell
525,892
-1,107
-0.2% -$1.55K ﹤0.01% 3452
2025
Q1
$770K Buy
526,999
+12,085
+2% +$21.4K ﹤0.01% 3396
2024
Q4
$1.08M Buy
514,914
+8,948
+2% +$17.5K ﹤0.01% 3348
2024
Q3
$1.06M Buy
505,966
+47,201
+10% +$69.8K ﹤0.01% 3332
2024
Q2
$661K Buy
458,765
+20,905
+5% +$29.3K ﹤0.01% 3465
2024
Q1
$635K Buy
437,860
+2,127
+0.5% +$3.02K ﹤0.01% 3525
2023
Q4
$654K Hold
435,733
﹤0.01% 3515
2023
Q3
$911K Sell
435,733
-1,514
-0.3% -$3.52K ﹤0.01% 3363
2023
Q2
$1.01M Hold
437,247
﹤0.01% 3356
2023
Q1
$944K Hold
437,247
﹤0.01% 3375
2022
Q4
$896K Buy
437,247
+4,374
+1% +$9.66K ﹤0.01% 3396
2022
Q3
$939K Buy
432,873
+2,499
+0.6% +$5.79K ﹤0.01% 3418
2022
Q2
$1.09M Sell
430,374
-21,136
-5% -$55.2K ﹤0.01% 3383
2022
Q1
$1.21M Buy
451,510
+844
+0.2% +$2.07K ﹤0.01% 3525
2021
Q4
$1.21M Buy
450,666
+12,885
+3% +$43.1K ﹤0.01% 3623
2021
Q3
$1.66M Buy
437,781
+61,947
+16% +$235K ﹤0.01% 3439
2021
Q2
$1.6M Sell
375,834
-325,794
-46% -$1.4M ﹤0.01% 3363
2021
Q1
$3.54M Buy
701,628
+68,294
+11% +$397K ﹤0.01% 2949
2020
Q4
$3.33M Buy
633,334
+26,118
+4% +$150K ﹤0.01% 2819
2020
Q3
$3.18M Buy
607,216
+17,323
+3% +$99.9K ﹤0.01% 2638
2020
Q2
$3.2M Buy
589,893
+26,278
+5% +$139K ﹤0.01% 2574
2020
Q1
$2.1M Buy
563,615
+22,999
+4% +$120K ﹤0.01% 2646
2019
Q4
$3.64M Buy
540,616
+5,630
+1% +$42.3K ﹤0.01% 2644
2019
Q3
$4.25M Buy
534,986
+10,709
+2% +$95.5K ﹤0.01% 2473
2019
Q2
$5.05M Buy
524,277
+91,975
+21% +$970K ﹤0.01% 2385
2019
Q1
$3.58M Buy
432,302
+15,721
+4% +$137K ﹤0.01% 2513
2018
Q4
$3.4M Buy
416,581
+24,391
+6% +$243K ﹤0.01% 2460
2018
Q3
$4.9M Buy
392,190
+24,065
+7% +$242K ﹤0.01% 2369
2018
Q2
$2.93M Buy
368,125
+29,200
+9% +$302K ﹤0.01% 2625
2018
Q1
$3.46M Buy
338,925
+106,514
+46% +$1.06M ﹤0.01% 2471
2017
Q4
$1.5M Buy
232,411
+5,853
+3% +$38.8K ﹤0.01% 2915
2017
Q3
$1.44M Buy
226,558
+4,851
+2% +$25.8K ﹤0.01% 2936
2017
Q2
$1.17M Buy
221,707
+10,895
+5% +$61.1K ﹤0.01% 3040
2017
Q1
$1.26M Buy
210,812
+8,996
+4% +$54.2K ﹤0.01% 2904
2016
Q4
$1.22M Buy
201,816
+6,847
+4% +$48.2K ﹤0.01% 2899
2016
Q3
$1.46M Buy
194,969
+3,648
+2% +$24.6K ﹤0.01% 2735
2016
Q2
$1.44M Buy
191,321
+45,150
+31% +$327K ﹤0.01% 2693
2016
Q1
$1.07K Buy
146,171
+27,242
+23% +$135K ﹤0.01% 2843
2015
Q4
$422K Hold
118,929
﹤0.01% 3351
2015
Q3
$337K Buy
118,929
+16,132
+16% +$55.1K ﹤0.01% 3422
2015
Q2
$406K Buy
102,797
+31,401
+44% +$124K ﹤0.01% 3293
2015
Q1
$251K Hold
71,396
﹤0.01% 3494
2014
Q4
$217K Hold
71,396
﹤0.01% 3549
2014
Q3
$213K Buy
71,396
+23,750
+50% +$54.2K ﹤0.01% 3548
2014
Q2
$96K Hold
47,646
﹤0.01% 3706
2014
Q1
$98K Hold
47,646
﹤0.01% 3666
2013
Q4
$101K Hold
47,646
﹤0.01% 3601
2013
Q3
$120K Buy
47,646
+5,541
+13% +$13.9K ﹤0.01% 3461
2013
Q2
$111K Buy
+42,105
New +$124K ﹤0.01% 3400

Other funds holding MNOV

Geode Capital Management's MNOV Position: Q1 2026 in Review

Geode Capital Management increased its MediciNova (MNOV) stake by 2.7% in Q1 2026, buying an estimated $21.6K and bringing the position to 543,843 shares worth $745K. The position accounts for ﹤0.01% of the portfolio, ranked #3450.

Geode Capital Management first reported a position in MNOV in Q2 2013 and has held it in 52 quarters since. The position peaked at $5.05M in Q2 2019. 30 funds tracked by Wall St. Rank hold MNOV as of Q1 2026.

  • Geode Capital Management held 543,843 shares of MediciNova worth $745K as of Q1 2026.
  • Geode Capital Management bought 14,260 MediciNova shares in Q1 2026, an estimated $21.6K.
  • MediciNova made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #3450 holding.
  • Geode Capital Management first reported a position in MediciNova in Q2 2013 and has held it in 52 quarters since.
  • Geode Capital Management's MediciNova position peaked at $5.05M in Q2 2019.
  • 30 funds tracked by Wall St. Rank held MediciNova as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.